We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




AI Tool Accurately Predicts Kidney Injury Signs In Critically Ill Patients

By HospiMedica International staff writers
Posted on 16 Jan 2024

Acute kidney injury (AKI), characterized by a rapid increase in serum creatinine or a decrease in urine output, is a primary cause of complications and increased mortality among patients in the intensive care unit (ICU). More...

Despite the importance of early detection and intervention in AKI, current monitoring methods like vital signs, blood tests, and urine analysis, fall short of offering effective solutions. Serum creatinine, a common diagnostic tool for AKI, is not always reliable for early detection. The rise of artificial intelligence (AI) has led to numerous machine-learning models that have shown high accuracy in predicting outcomes for ICU patients, including AKI detection. However, the use of machine learning to predict oliguria, a critical component of AKI that is associated with higher mortality, has not been extensively researched.

Researchers at Chiba University Graduate School of Medicine (Chiba, Japan) have developed a machine-learning model that could predict the onset of oliguria in ICU patients. They developed the model and assessed its accuracy using data from a large, single-center surgical/medical mixed ICU. The model was based on 28 clinically relevant variables, including urine output, SOFA score, serum creatinine, pO2, FDP, IL-6, and peripheral temperature. It showed a high Area Under the Curve (AUC) of over 0.90 for predicting oliguria between 6 to 72 hours. This high accuracy was attributed to the large dataset of over 10,000 patients, providing extensive training data. The model’s high accuracy and capability to predict oliguria over longer periods with the AUC remaining unchanged even after reducing the variables in the model development indicate its robustness.

In addition, the method of predicting the onset of oliguria from an arbitrary time could have improved the accuracy by increasing the number of training datasets. The model was built based on 28 clinically relevant variables although the overlap of the top-listed variables in the model with those in a dataset of 1,018 values supports the viability of the chosen variables for prediction. Given that oliguria can identify AKI earlier than serum creatinine and is linked to poor outcomes in critically ill patients, this machine-learning model could be instrumental in early AKI detection. This early detection could lead to better patient management and timely interventions, potentially improving the prognosis for this patient group.

Related Links:
Chiba University Graduate School of Medicine


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.